Clinical Trials Logo

Clinical Trial Summary

To learn about the attitudes and beliefs towards vaccination both before and after the COVID-19 pandemic in patients who have received supportive care.


Clinical Trial Description

Primary Objective: Our primary objective is to assess patient perception of efficacy and safety of vaccinations. Secondary Objectives: To assess demographic predictors of those who would be considered as vaccine hesitant. To assess patient preferred source of recommendations for or against vaccination. To assess the role past side effects or allergic reactions play on patient perception of future vaccines. To assess patient perception of vaccination prior to COVID-19. To assess patient willingness to get the COVID-19 vaccine. To assess patient willingness to get the influenza vaccine. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05329506
Study type Observational
Source M.D. Anderson Cancer Center
Contact
Status Active, not recruiting
Phase
Start date March 10, 2022
Completion date February 1, 2026

See also
  Status Clinical Trial Phase
Completed NCT03975517 - Sexual Risks in Prep Users
Recruiting NCT05302908 - COVID-19 Testing and Vaccination Among Spanish Speakers N/A
Completed NCT03428776 - Timeliness of Immunization and Compliance Assessment Study N/A